(19)

(11)

EP 4 815 825 A1

(12)

(43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24828244.4 (22) Date of filing: 27.11.2024

(51) International Patent Classification (IPC):  A61B 5/11(2006.01) G16H 20/70(2018.01) G16H 30/40(2018.01) G16H 50/20(2018.01) G06V 40/20(2022.01) G16H 30/20(2018.01) G16H 40/67(2018.01) G16H 50/70(2018.01) (52) Cooperative Patent Classification (CPC): G16H 30/40; A61B 5/112; G16H 50/20; G16H 40/67; G06V 40/25; G16H 30/20; G16H 50/70; G16H 20/70 (86) International application number: PCT/US2024/057831 (87) International publication number: WO 2025/117801 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.12.2023 US 202363605194 P (71) Applicant: GENZYME CORPORATION Cambridge, Massachusetts 02141 (US)	(72) Inventors: SARKER, Hillol Cambridge, Massachusetts 02141 (US) GARGAUN, Elena Cambridge, Massachusetts 02141 (US) TANG, Qi Cambridge, Massachusetts 02141 (US) (74) Representative: McDougall, James et al Venner Shipley LLP TIDE Bankside 8 Emerson Street London SE1 9DU London SE1 9DU (GB)